Related references
Note: Only part of the references are listed.LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice
Honglin Tan et al.
CELL DEATH AND DIFFERENTIATION (2020)
Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide
Tengfei Li et al.
CANCER CELL INTERNATIONAL (2020)
Mitochondrial carrier homolog 2 is necessary for AML survival
Dilshad H. Khan et al.
BLOOD (2020)
Integrated Approach Reveals Role of Mitochondrial Germ-Line Mutation F18L in Respiratory Chain, Oxidative Alterations, Drug Sensitivity, and Patient Prognosis in Glioblastoma
Kathleen Keatley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A glial blueprint for gliomagenesis
Dylan Laug et al.
NATURE REVIEWS NEUROSCIENCE (2018)
An anatomic transcriptional atlas of human glioblastoma
Ralph B. Puchalski et al.
SCIENCE (2018)
MTCH2-mediated mitochondrial fusion drives exit from naive pluripotency in embryonic stem cells
Amir Bahat et al.
NATURE COMMUNICATIONS (2018)
Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression
Sara Franceschi et al.
EBIOMEDICINE (2018)
Cancer metabolism: a therapeutic perspective (vol 14, pg 11, 2017)
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity (Vol 14, Pg 1602, 2016)
Liat Buzaglo-Azriel et al.
CELL REPORTS (2017)
NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin
Paula Schiapparelli et al.
EBIOMEDICINE (2017)
Loss of forebrain MTCH2 decreases mitochondria motility and calcium handling and impairs hippocampaldependent cognitive functions
Antonella Ruggiero et al.
SCIENTIFIC REPORTS (2017)
Metabolic Reprogramming in Glioma
Marie Strickland et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Expression and putative role of mitochondrial transport proteins in cancer
Oleksandr Lytovchenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)
Mitochondrial control by DRP1 in brain tumor initiating cells
Qi Xie et al.
NATURE NEUROSCIENCE (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
An MTCH2 pathway repressing mitochondria metabolism regulates haematopoietic stem cell fate
Maria Maryanovich et al.
NATURE COMMUNICATIONS (2015)
Structural insights into proapoptotic signaling mediated by MTCH2, VDAC2, TOM40 and TOM22
Valery G. Veresov et al.
CELLULAR SIGNALLING (2014)
Interactions among mitochondrial proteins altered in glioblastoma
Ruth F. Deighton et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
miR-135b Coordinates Progression of ErbB2-Driven Mammary Carcinomas through Suppression of MIDI. and MTCH2
Maddalena Arigoni et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Mitochondrial carrier homolog 2 (MTCH2): The recruitment and evolution of a mitochondrial carrier protein to a critical player in apoptosis
Alan J. Robinson et al.
EXPERIMENTAL CELL RESEARCH (2012)
Molecular Basis of the Interaction between Proapoptotic Truncated BID (tBID) Protein and Mitochondrial Carrier Homologue 2 (MTCH2) Protein KEY PLAYERS IN MITOCHONDRIAL DEATH PATHWAY
Chen Katz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A BID on mitochondria with MTCH2
Sara Cogliati et al.
CELL RESEARCH (2010)
MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria
Yehudit Zaltsman et al.
NATURE CELL BIOLOGY (2010)
Metabolic Modulation of Glioblastoma with Dichloroacetate
E. D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release
S. Alcala et al.
ONCOGENE (2008)
Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways
Raya Leibowitz-Amit et al.
CANCER RESEARCH (2006)
Culturing hippocampal neurons
Stefanie Kaech et al.
NATURE PROTOCOLS (2006)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Share Paper
